Twins getting what they paid for with Crede

Leave a comment

Joe Crede is once again out of the Twins’ lineup, this time with complications from last year’s back surgery. He dropped into Minnesota’s price range this offseason following multiple back surgeries and various other health problems, and had to settle for an incentive-laden one-year deal after eight seasons in Chicago.
Despite having to accumulate plate appearances to make money Crede has played in just 88 of 126 games, and the amazing thing is that he’s been out of the lineup 30 percent of the time without spending a second on the disabled list. Instead he’s missed 3-5 games every couple weeks, leaving the Twins to play with a 24-man roster for long stretches while essentially being “day-to-day” for five months.
When healthy enough to play Crede provided some nice power in April and May, hitting .239/.304/.493 with nine homers in 37 games to go along with outstanding defense at third base. Unfortunately he’s hit just .222/.285/.371 with six homers in 51 games since then, and his various maladies have left the Twins sharing the other 42 starts among the fearsome foursome of Brendan Harris, Brian Buscher, Matt Tolbert, and Nick Punto.
Not coincidentally the Twins rank 11th in the 14-team league with a measly .695 OPS from third base, which is nothing new for them. Corey Koskie was Minnesota’s third baseman from 1999 to 2004, hitting .280/.373/.463 with 52 extra-base hits per 500 at-bats, but since losing him to free agency five years ago Twins third basemen have ranked 10th, 13th, 14th, 11th, and 11th in OPS among AL teams.

Jake Diekman will miss at least half of the 2017 season

TORONTO, ON - OCTOBER 9: Jake Diekman #41 of the Texas Rangers works against the Toronto Blue Jays in the sixth inning during game three of the American League Division Series at Rogers Centre on October 9, 2016 in Toronto, Canada. (Photo by Tom Szczerbowski/Getty Images)
Tom Szczerbowski/Getty Images
Leave a comment

Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.

Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.

The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.

The Blue Jays and Bautista have reached a one year deal

TORONTO, ON - OCTOBER 19:  Jose Bautista #19 of the Toronto Blue Jays looks on during batting practice prior to game five of the American League Championship Series against the Cleveland Indians at Rogers Centre on October 19, 2016 in Toronto, Canada.  (Photo by Vaughn Ridley/Getty Images)
Getty Images
2 Comments

It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.

The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.

Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.